Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 Patients

Purpose: Whether hypertension is an independent risk factor for the severity of COVID-19 symptoms and COVID-19 mortality is still unclear. In this study, it was aimed to investigate the effect of hypertension independently in the course of COVID-19 by comparing clinical characteristics and laborator...

Full description

Bibliographic Details
Main Author: Mustafa KUZEYTEMİZ
Format: Article
Language:English
Published: Kirsehir Ahi Evran University 2021-12-01
Series:Ahi Evran Medical Journal
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/1465068
_version_ 1797912179972767744
author Mustafa KUZEYTEMİZ
author_facet Mustafa KUZEYTEMİZ
author_sort Mustafa KUZEYTEMİZ
collection DOAJ
description Purpose: Whether hypertension is an independent risk factor for the severity of COVID-19 symptoms and COVID-19 mortality is still unclear. In this study, it was aimed to investigate the effect of hypertension independently in the course of COVID-19 by comparing clinical characteristics and laboratory measurements in COVID-19 patients with and without preexisting hypertension. Materials and Methods: Fifty COVID-19 patients under the age of 45 with preexisting hypertension without accompanying chronic diseases were compared with 50 normotensive COVID-19 patients. All patients received the same treatment protocol. The frequency of symptoms, blood levels of inflammatory markers, length of hospital stay, intensive care unit (ICU) requirement, and mortality rates were compared between the groups. Results: Peak leukocyte count (8.1±2.7 x 103/mm3 vs. 6.9±1.9x103/mm3, p=0.012), peak C-reactive protein (52.7±9.7mg/L vs. 18.9±3.7 mg/L, p=0.024), and peak erythrocyte sedimentation rate (ESR) (55.5±5.7 mm/h, vs. 33.4±5.1 mm/h, p<0.01) were significantly higher in hypertensive patients compared to normotensive ones (all values respectively). Hospital stay duration was significantly longer in hypertensive patients than the normortensive ones. (hypertensive group 11±2.4 days; normotensive group 9.1±2.2 days, p=0.001). Conclusions: COVID-19 patients having hypertension have higher levels of inflammatory markers, higher levels of troponin, and longer hospital stay compared to COVID-19 subjects without hypertension. It appears that hypertensive patients tend to have a more severe COVID-19 infection than normotensive patients.
first_indexed 2024-04-10T11:53:27Z
format Article
id doaj.art-21efe517ef604a369c2a040abaac6a74
institution Directory Open Access Journal
issn 2619-9203
language English
last_indexed 2024-04-10T11:53:27Z
publishDate 2021-12-01
publisher Kirsehir Ahi Evran University
record_format Article
series Ahi Evran Medical Journal
spelling doaj.art-21efe517ef604a369c2a040abaac6a742023-02-15T16:17:01ZengKirsehir Ahi Evran UniversityAhi Evran Medical Journal2619-92032021-12-0153223228https://doi.org/10.46332/aemj.845972Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 PatientsMustafa KUZEYTEMİZ0https://orcid.org/0000-0002-3316-2490bursa yüksek ihtisas eğitim araştırma hastanesiPurpose: Whether hypertension is an independent risk factor for the severity of COVID-19 symptoms and COVID-19 mortality is still unclear. In this study, it was aimed to investigate the effect of hypertension independently in the course of COVID-19 by comparing clinical characteristics and laboratory measurements in COVID-19 patients with and without preexisting hypertension. Materials and Methods: Fifty COVID-19 patients under the age of 45 with preexisting hypertension without accompanying chronic diseases were compared with 50 normotensive COVID-19 patients. All patients received the same treatment protocol. The frequency of symptoms, blood levels of inflammatory markers, length of hospital stay, intensive care unit (ICU) requirement, and mortality rates were compared between the groups. Results: Peak leukocyte count (8.1±2.7 x 103/mm3 vs. 6.9±1.9x103/mm3, p=0.012), peak C-reactive protein (52.7±9.7mg/L vs. 18.9±3.7 mg/L, p=0.024), and peak erythrocyte sedimentation rate (ESR) (55.5±5.7 mm/h, vs. 33.4±5.1 mm/h, p<0.01) were significantly higher in hypertensive patients compared to normotensive ones (all values respectively). Hospital stay duration was significantly longer in hypertensive patients than the normortensive ones. (hypertensive group 11±2.4 days; normotensive group 9.1±2.2 days, p=0.001). Conclusions: COVID-19 patients having hypertension have higher levels of inflammatory markers, higher levels of troponin, and longer hospital stay compared to COVID-19 subjects without hypertension. It appears that hypertensive patients tend to have a more severe COVID-19 infection than normotensive patients.https://dergipark.org.tr/tr/download/article-file/1465068covi̇d19sarscov-2mortalityhypertension
spellingShingle Mustafa KUZEYTEMİZ
Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 Patients
Ahi Evran Medical Journal
covi̇d19
sarscov-2
mortality
hypertension
title Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 Patients
title_full Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 Patients
title_fullStr Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 Patients
title_full_unstemmed Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 Patients
title_short Does Hypertension Alone Increase Mortality in Young Hypertensive Patients Having COVID-19? Single Center Retrospective Study of 100 Patients
title_sort does hypertension alone increase mortality in young hypertensive patients having covid 19 single center retrospective study of 100 patients
topic covi̇d19
sarscov-2
mortality
hypertension
url https://dergipark.org.tr/tr/download/article-file/1465068
work_keys_str_mv AT mustafakuzeytemiz doeshypertensionaloneincreasemortalityinyounghypertensivepatientshavingcovid19singlecenterretrospectivestudyof100patients